Objective: Development of late significant tricuspid regurgitation (TR) after successful mitral valve replacement (MVR) is not infrequent. The impact of different aetiologies or diverse surgical procedures has not been adequately investigated. We studied the influence of subvalvular preservation techniques during MVR on the incidence of late TR. Methods: A total of 801 patients with grade 2+/4+ preoperative TR underwent MVR without associated tricuspid procedures from January 1994 to August 2008. In 595 patients, only posterior mitral leaflet preservation was performed (group A). In the remaining 206 patients, both anterior and posterior leaflets were retained (group B). Postoperative development of significant TR was defined as a TR increase by more than one grade from preoperative or final TR grade !3+/4+ at follow-up. Results: The global incidence of postoperative significant TR was 8.6%, with higher incidence in females (9.4% vs 6.7%, p = 0.12), rheumatic disease (9.7% vs 6.5%, p = 0.07), patients with previous AF (11.8% vs 3.8%, p < 0.001) and, especially, in group A (10.8% vs 2.4%, p < 0.001). The Maze procedure was protective in patients with AF (the incidence with and without associated Maze was 6.7% vs 13.2%, p = 0.04). Preoperative left-atrial diameters were higher in patients with postoperative development of TR (56 AE 9 mm vs 51 AE 12 mm, p = 0.01). Group A ( p = 0.04) and preoperative atrial fibrillation ( p = 0.001) were significant predictors of late postoperative TR. Late functional TR decreased free survival from chronic heart failure. Conclusions: Several clinical and operative factors are associated with the development of significant TR after MVR. Although early surgical intervention for TR may be recommended in selected patients, complete subvalvular preservation of the mitral valve and routine surgical ablation of atrial fibrillation can significantly reduce its incidence. #
Introduction
Significant functional tricuspid regurgitation (TR) developing in patients, who had undergone uneventful left-sided valve surgery, is not a rare event [1] [2] [3] [4] [5] . Although several long-term follow-up studies have evaluated its incidence and associated risk factors, the impact of different surgical procedures performed on the mitral valve (MV) has not been adequately investigated [1, 2, [6] [7] [8] . Moreover, the real clinical outcomes of late TR have not been assessed. Most of these studies have included organic TR patients, or only patients with rheumatic valvular disease, or with a variety of MV techniques (repair and replacement), or concomitant procedures as coronary artery bypass grafting (CABG), or aortic valve replacement (AVR).
Resection of chordopapillary apparatus during mitral valve replacement (MVR) has been associated with a negative impact on postoperative left-ventricular remodelling and survival. On the contrary, more favourable remodelling has been observed with the use of subvalvular preservation techniques [9] [10] [11] [12] . There are few data available to clarify the relative effects of partial versus complete preservation of both anterior and posterior chordopapillary apparatus in MVR [9, 13, 14] . Consequently, our aim was to compare both strategies with a focus on the impact of partial or complete preservation of chordopapillary apparatus in the development of late functional TR in patients undergoing MVR. We have also analysed the incidence, clinical impact and other risk factors associated with this postoperative event.
Materials and methods

Study group
We reviewed all the patients undergoing successful MVR at our institution from January 1994 to August 2008 (n = 1208). Previous MV operation, other approaches than median sternotomy, emergent operation (carried out on referral before the beginning of the next working day), concomitant coronary artery disease or CABG, tricuspid valve surgery, organic TR or preoperative functional TR grade !3/4 according to preoperative echocardiography were not considered (n = 407). In this series of patients, concomitant tricuspid annuloplasty was considered according to the preoperative degree of TR. Functional TR grade !3/4 was the main indication, irrespective of the tricuspid annulus diameter. Concomitant procedures such as AVR or Maze operation were not discarded. The final cohort comprised 801 patients undergoing MVR with untreated functional TR grade 2/4 and no evidence of rheumatic involvement of the tricuspid valve on preoperative echocardiography. The study was approved by the Institutional Review Board with patient consent waived.
Surgical technique and patient subgroups
Operative data were retrospectively extracted from medical records, surgery notes and the computer-based databank from the Department of Cardiac Surgery. The operative technique was at the discretion of the surgeon. Intra-operative trans-oesophageal echocardiography was routinely used and the surgeons attempted to retain the mitral subvalvular tissue whenever possible. In some patients, the anterior leaflet was completely excised and a partial or complete preservation of the posterior leaflet was performed (group A, n = 595 patients). These patients had more frequently redundant or excessive cuspal tissue, subvalvular fusion, extensive scarring and shortening or calcification of the anterior chordopapillary apparatus. In other patients, both anterior and posterior chordopapillary apparatus were preserved (group B, n = 206 patients) by means of two techniques. In some of them, the anterior leaflet was divided into two or more segments and reattached to the annulus, according to the procedure described by Miki et al. [15] . In other patients (n = 86), a technique of posterior (or oblique) transposition of the anterior leaflet, previously described by us [16] , was performed. In this technique, more frequently performed during the recent years, the whole anterior leaflet is completely detached from commissure to commissure and reimplanted as a large patch. Bioprosthetic valves were implanted in 123 (20.7%) and 53 patients (25.7%) in groups A and B.
Clinical and echocardiographic follow-up
Follow-up data were analysed by using Cardiology and Cardiac Surgery outpatient follow-up notes, primary care and institutional computer-based databanks, national death index and telephone interviews.
Survivors were studied by echocardiography (HewlettPackard Sonos 5500; Andover, MA, USA) with a 2.7-or 3.5-MHz transducer) preoperatively, at discharge (or first month) and at mid-term follow-up (6 months to 1 year; mean 9 AE 3 months). Thereafter, an annual examination was recommended. Complete preoperative, first-month and mid-term postoperative echocardiographic data were available. Moreover, all survivors had registered data from at least one echocardiographic study at late follow-up. Preoperative and postoperative TR grade was assessed by means of the maximal TR jet area visualised using colour Doppler flow mapping, with a TR jet-to-right atrial area ratio of <10% = grade 1+, 10-20% = grade 2+, 20-40% = grade 3+ and >40% = grade 4+. Systolic reversal of hepatic venous flow was also used as a criterion for 4+ TR. The measured peak systolic TR jet velocity was used to calculate the TR peak pressure gradient using the simplified Bernoulli equation to estimate the peak systolic pulmonary artery pressure. The absence of rheumatic tricuspid valvular heart disease was confirmed by careful evaluation of valvular morphology by echocardiography. The presence of commissural fusion and multivalvular involvement with thickening and motion limitation of leaflets were suggestive of rheumatic disease.
Definitions
Development of late, significant TR was defined as a TR increase by more than one grade with respect to the preoperative one or final TR grade !3+ on follow-up echocardiography. Increase in TR grade from 0+ at baseline to 2+ at follow-up was included in this definition. Chronic renal failure was defined as creatinine !2 mg dl À1 . Chronic obstructive pulmonary disease was defined as the need for pharmacologic therapy for chronic pulmonary compromise or espirometry with moderate-severe obstruction. Urgent operation was considered when the procedure was performed during the hospital stay of an acute episode. Emergency status was excluded. Thirty-day mortality was defined as death within 30 days of operation, regardless of the patient's geographic location. Definitions and reporting mortality and morbidity after MV operations were managed according to published guidelines [17] .
Statistical analysis
Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) 12.0 for Windows (SPSS Corp, Birmingham, AL, USA). Continuous variables were summarised as mean AE SD, if normally distributed; if not, median and inter-quartile ranges were used. Nominal data were presented as frequencies and percentages. Two groups of continuous variables were compared by unpaired t-test. The Mann-Whitney test was used if data were not normally distributed. Associations among categorical variables were compared by Pearson's chi-square test, continuity correction or two-sided Fisher's exact test.
Univariate analyses of risk factors for in-hospital and long-term mortality were performed. All variables with pvalue < 0.10 were entered into a subsequent multivariate analysis. Stepwise logistic regression was used to assess the independent impact of the risk factor on the occurrence of in-hospital mortality (selection cut-off set at 0.05). Hosmer-Lemeshow goodness-of-fit statistic and the area under the receiver operating characteristic (ROC) curve were calculated. Cox regression analysis was used to identify predictors for late death. Moreover, univariate analysis of predictors for development of significant functional TR at follow-up was performed with logistic regression, and variables with a p-value < 0.10 were entered into a multivariable model. Non-parametric estimates of death and freedom from functional TR were determined using the Kaplan-Meier method. Differences in survival curves were analysed with the log-rank test.
To control for selection bias in the comparison among the two study groups, a propensity score (PS) analysis was performed. One PS was calculated for each patient from the global group by means of logistic regression analysis using preoperative and surgical variables. A saturated model was constructed and PS was defined as the estimated probability of patient assignment to each surgical group, given the observed baseline factors and covariables. PS was directly used as a continuous variable to adjust multivariable models to estimate the treatment effect.
Results
Pre-and operative data
Patient characteristics and operative data from both study groups are shown in Table 1 . No significant differences were observed between groups with respect to most of the preoperative and surgical variables. The underlying MV disease was dominant mitral stenosis in 286 (48.1%) and 85 (41.3%) patients, mitral regurgitation in 160 (26.9%) and 73 (35.4%) patients and mixed lesion in 149 (25.0%) and 48 (23.3%) patients. Group A showed a higher prevalence of atrial fibrillation (AF) ( p = 0.06), but the frequency of concomitant Maze procedure and type of implanted prosthetic valves were similar. No differences were observed with respect to the preoperative severity of functional TR and aetiology of MV disease.
Incidence of late significant TR and related factors
The overall incidence of late significant functional TR was 8.6% (69/801). Fig. 1 summarises the changes of TR severity. Before surgery, 600 patients showed TR grade 1+, and grade 2+ TR was present in 201 patients. On the one hand, in patients with preoperative TR grade 1+, 54 patients developed significant TR at follow-up and 18 patients without preoperative TR showed final TR grade 2+. On the other hand, 15 patients showed development of significant TR in patients with preoperative grade 2+ TR.
The incidence of late, significant, functional TR was more frequently associated with several factors. Patients with rheumatic MV aetiology had an incidence of 9.7% in comparison to 6.5% in the non-rheumatic group ( p = 0.07). Compared with males, females showed a higher incidence of late significant TR: 9.4% versus 6.7% ( p = 0.12). A total of 484 patients (60.4%) had preoperative AF, and this factor was found to be significantly associated with development of late TR (an incidence of 11.8% vs 3.8% in patients with and without AF, p < 0.001). The Maze operation showed a protective effect in these patients, with an incidence of 6.7% of late, significant TR in comparison to 13.2% in those patients without Maze ( p = 0.04). Recurrent AF was invariably present in those patients, who developed late TR in spite of a previous Maze procedure. The left-atrial diameter was higher in those patients, who developed late TR (56 AE 9 mm vs 51 AE 12 mm, p = 0.01). When MV subvalvular preservation techniques were considered, group A showed a higher incidence of late TR than group B: 10.8% versus 2.4% ( p < 0.001). In the global group, 1-and 5-year freedom from functional TR was 96 AE 0.6% and 90 AE 1.1% ( Fig. 2(A) ). These values were significantly higher in group B: 99 AE 0.5% versus 95 AE 0.8% and 97 AE 1.4% versus 88 AE 1.3% ( p < 0.01) ( Fig. 2(B) ). [ ( ) T D $ F I G ] [ ( ) T D $ F I G ] Multivariable analysis showed that preoperative AF and partial versus complete MV chordopapillary preservation (group A vs group B) were independent predictors of late functional TR (Table 2 ).
Early outcomes
There were 44 early deaths (30-day mortality: 5.5%): 34 (5.7%) and 10 (4.9%) in groups A and B, respectively ( p = 0.39). All were in-hospital deaths and their main causes were low cardiac output syndrome (15 and one patients, respectively), pneumonia or sepsis (six and three), multiorgan failure (five and three) and endocarditis (three and one). Other causes of death were stroke (two patients in each group), respiratory distress syndrome (two patients in group A) and ventricular arrhythmia (one patient in group A).
A higher incidence of postoperative low cardiac output syndrome and cardiac-related death was observed in group A: 47 (7.9%) versus five (2.4%), p = 0.005; 19 (3.2%) versus two (1.0%), p = 0.12. Other postoperative complications were similar in both groups.
Univariable and multivariable predictors of in-hospital mortality are depicted in Table 3 . A PS-adjusted model is also included.
Late outcomes 3.4.1. Survival
Completeness of follow-up was 98% in both groups, with a mean period of 88 AE 54 (range, and 75 AE 47 months (range, 16-175 months). There were 139 late deaths (17.4%): 123 (20.7%) and 16 (7.8%), respectively ( p < 0.001). Overall survival was higher with complete than with partial mitral subvalvular preservation techniques with 5-and 12-year actuarial survival of 93 AE 2% versus 90 AE 1% and 79 AE 9% versus 70 AE 2% ( p = 0.07) (Fig. 3(A) ). This was particularly true in the subgroup of patients with preoperative 2+ functional TR, in which this difference was statistically significant ( p = 0.01) (Fig. 3(B) ).
Cardiac-related deaths (related to congestive heart failure, myocardial infarction, cardiac arrest or sudden death) were more frequent in group A: 106 (17.8%) and six (4.3%), in the respective groups ( p < 0.001). Other causes of late death were cancer (three and two patients), cerebrovascular accident (five and three patients), pneumonia or sepsis (four and three patients), renal failure (one patient in groups A and B), aortic dissection (one patient in group A), trauma (one patient in group B), suicide (one patient in group A) and unknown (two patients in group A).
Independent risk factors for late mortality are also shown in Table 3 .
Valve-related events
At last follow-up, 42% (184 patients) of survivors in group A remained in AF compared with 23.9% (43 patients) in group B ( p < 0.001). Chronic anticoagulation was maintained in 449 patients (311 and 138 patients, in the respective groups). A trend to more frequent thrombo-embolic complications was observed in group A ( p = 0.09): 27 (4.8%) and four patients (2.0%) with rates of 0.75 and 0.54 events per 100 patientyears in the respective groups. However, there were no differences in anticoagulant-related haemorrhage ( p = 0.81): 18 (3.2%) and five patients (2.5%) with 0.61 and 0.56 major bleeding events per 100 patient-years, respectively. At follow-up, prosthetic valve endocarditis developed in four patients from group A (0.7%; 0.23 events per 100 patient-years) and in two patients from group B (1.0%; 0.26 events per 100 patient-years). Ten patients underwent MV reoperation at follow-up: six (1.1%) and four patients (2.0%), in the respective groups ( p = 0.29). Four and two patients had developed late, functional TR. In groups A and B, the reoperations were due to paravalvular leak (three and one patients) and structural bioprosthetic valve deterioration (three patients each). Partial bioprosthetic leaflet fusion to the preserved subvalvular tissue was observed in two patients from group B. Both patients had been operated on for Barlow's disease, according to the procedure described by Miki et al. [15] . Another patient from group A underwent reoperation for severe aortic valve stenosis.
Clinical impact of development of late functional TR
Patients who developed late significant TR showed a significantly lower 12-year free survival from chronic heart failure compared with those without late TR: 87 AE 4% versus 96 AE 1% ( p < 0.01) (Fig. 4(D) ). By contrast, no differences were observed in overall survival (Fig. 4(C) ). Higher grades of preoperative TR had a higher impact in those patients undergoing partial subvalvular preservation procedures. Patients with preoperative 2+ TR only showed a trend to lower survival than those patients with 0-1+ TR in the global group (Fig. 4(A) ), but this difference was higher if only group A was considered (Fig. 4(B) ).
Echocardiographic follow-up
Echocardiographic data are shown in Table 4 . Preoperatively, left-ventricular (LV) diameters were higher in group B, but a significant reduction was observed during the postoperative period. At late follow-up, these parameters were lower in group B in comparison to group A. In both groups, LV diameters had a significant decrease at early stages but, thereafter, a different behaviour was observed in group A. Progressive LV diameter reduction was maintained in group B; meanwhile, in group A, a gradual increase was observed at late follow-up. Only minor changes were observed in left-ventricular ejection fraction (LVEF) with only a trend to higher postoperative increase in group B. Pulmonary artery systolic pressure and left-atrial diameter decreased in both groups, but a trend to a more pronounced reduction was observed in group B.
The echocardiographic outcome of patients, who developed late functional TR, was indicative of that of patients from group A, with only a trend to initial decrease of LV diameters followed by gradual posterior increase. On the contrary, a trend to progressive and sustained decrease was experienced by those patients without late functional TR. Interestingly, preoperative left-atrial diameter was significantly higher in patients, who developed late TR, and this was followed by an incomplete postoperative left-atrial [ ( ) T D $ F I G ] reduction in comparison to those patients without late TR. Although preoperative pulmonary artery systolic pressure was similar in both groups, a lower initial decrease was observed in patients, who developed late TR. Thereafter, these patients experienced a subsequent late increase of pulmonary pressure. Right ventricular diameter significantly increased at follow-up in those patients, who developed TR.
Discussion
The challenge of preserving the native valve apparatus in MV surgery
MV surgery aims to correct haemodynamics without damaging LV function. An increased awareness that ventricular function deteriorates with chordal transection during MVR has led to an emphasis on repair or replacement methods that preserve annulo-ventricular continuity. The direct consequence of this preservation was the improvement of both early and long-term results of MV operations [9] [10] [11] [12] . However, complete preservation is often hindered by several factors such as valve pathology, greater technical complexity and concerns about interference with the prosthetic valve or LV outflow tract obstruction. Thus, many surgeons continue to retain only the posterior leaflet.
The MV-left-ventricular complex constitutes a structural and functional unit in which the mitral annulus, chordopapillary apparatus and ventricular wall are all important determinants of LV geometry and function [18, 19] . Hansen et al. [20] found that section of the chordae to the anterior leaflet had a considerably more deleterious effect on LV systolic function than section of the chordae to the posterior leaflet. This observation has been explained by the concept of regional afterload reduction. The anterior leaflet is larger and development of tension in the chordae to this leaflet should be greater at a given LV pressure. Moreover, the anterior MV leaflet second-order (or 'strut') chordae are involved in valvular-ventricular interaction and transection of these chordae would adversely perturb regional LV systolic function [19] .
Development of late significant functional TR after successful left-sided valve surgery
Significant functional TR developing in patients, who had undergone uneventful left-sided valve surgery, is not a rare event [1] [2] [3] [4] [5] 21] . Moreover, its clinical impact and associated risk factors have not been adequately investigated. According to Song et al. [1] , the overall incidence of late significant TR after successful left-sided valve surgery was 7.7%, and these patients showed a significantly lower 8-year clinical event-free survival. Age, female gender, rheumatic aetiology, AF and peak pressure gradient of TR at follow-up were the most important independent risk factors. Their results confirmed that elevated or persistent pulmonary artery pressure at follow-up was an important risk factor for the development of significant postoperative functional TR. On the contrary, they did not find preoperative pulmonary hypertension to be associated with TR progression. In our present study, the incidence of late functional TR was similar (8.6%), and these patients showed a significantly lower 12-year free survival from chronic heart failure. No differences were observed in preoperative pulmonary artery systolic pressure between the groups of patients with and without development of late TR. However, a lower initial decrease in pulmonary artery pressure was observed in those patients, who finally developed TR followed by a subsequent late increase.
According to other published studies, huge left atrium and AF are other predictors of significant late TR after MV surgery without TV surgery [2, 22, 23] . Some authors have proposed an aggressive repair of accompanying TR in these patients, even if preoperative TR is 2+ [2] . However, although TV repairs alleviate the progression of functional TR, other concomitant procedures may be important to prevent late TR. Je et al. [23] concluded that concomitant Maze operation is a more powerful protective factor against mild functional TR progression in patients with AF. In our study, AF and enlargement of left atrium were also associated with the development of functional TR, and restoration of sinus rhythm by the Maze procedure was a protective factor.
Does replacement with complete preservation of chordopapillary apparatus make any difference?
In our previous experience [9] , superior results in terms of preservation of LV function and survival were obtained with complete preservation of subvalvular apparatus in comparison to partial preservation in a large group of rheumatic patients.
In our present study, several important findings must be considered:
(1) although no important differences were observed with respect to several valve-related events in both study groups, failure to preserve both anterior and posterior chordopapillary apparatus was associated with lower late survival; (2) this finding was particularly significant when cardiacrelated death was considered or in patients with higher grades of preoperative TR (2+ TR vs 0-1+ TR); (3) conversely, higher grades of preoperative TR did not impact survival significantly in the global group; but, when only group A was considered, preoperative 2+ TR was associated with a lower survival in comparison with 0-1+ TR; (4) interestingly, the incidence of late significant functional TR following successful MVR was significantly associated with failure to perform a complete preservation of both anterior and posterior chordopapillary apparatus; consequently, freedom from late functional TR was significantly lower in patients from group A; and (5) although no differences were observed in overall survival, patients who developed late functional TR had a lower free survival from chronic heart failure compared with those patients without late TR.
According to our echocardiographic data, different postoperative geometrical changes in cardiac chambers were observed in patients undergoing MVR with partial subvalvular preservation. Pulmonary artery systolic pressure and left-atrial diameter had a lower decrease in these patients with a higher persistence of elevated values at follow-up. All these changes could explain the observed differences in clinical outcomes between both study groups. Many studies have demonstrated that LV dimensions and function are improved with mitral subvalvular preservation [9] [10] [11] [12] . Consequently, LV ejection and pulmonary hypertension may also improve with time because of more favourable LV remodelling. Moreover, according to Le Tourneau et al. [12] , anterior chordal transection induces significant impairment of regional function in the apicoseptal area of the right ventricle. Persistence of elevated pulmonary artery pressure in conjunction with these postoperative regional contractile abnormalities may participate in the observed impairment of right ventricular function and functional TR after MVR. In the present study, the development of late functional TR was particularly favoured in those patients with preoperative AF and enlargement of left atrium who underwent MVR with only partial preservation of chordopapillary apparatus and no concomitant Maze operation. Continued AF and geometrical and functional changes induced by chordal transection may have been responsible for late development of significant functional TR.
In conclusion, the development of late significant functional TR after MVR is not a rare event, with a negative impact on long-term free survival from chronic heart failure. AF, enlargement of left atrium and chordal transection during MVR are important contributing factors. Although an aggressive repair of accompanying TR may be recommended in patients at risk, other concomitant procedures as the Maze operation and complete preservation of chordopapillary apparatus may be more powerful protective factors against mild functional TR progression after MVR.
Limitations of the study
A retrospective, non-randomised single-centre analysis over a long period of time and with a variety of techniques and prostheses on patients undergoing MVR for MV disease from different aetiologies is subjected to the effects of selection bias. Nevertheless, no relevant differences among the study groups were found at baseline, and PS adjustment has been used in addition to multivariable analyses to reduce the effect of selection bias. The choice of surgical procedure was surgeon dependent, and some surgeons were somewhat more likely than others to elect valve replacement with complete chordopapillary preservation. For this reason, the variable 'surgeon' was included in the PS model.
Retrospective data about intra-operative failures of MVR with complete subvalvular preservation and subsequent conversion to replacement with chordal transection were not complete; consequently, the resulting final operative procedure was considered in the analysis.
We could not analyse retrospectively some important echocardiographic data about the function of the right ventricle and tricuspid annular size. Future studies must address the relationship between the occurrence of late TR and right ventricular dysfunction or tricuspid annulus dilatation.
The follow-up period ranged from 16 to 192 months. For patients with a short follow-up period, the study duration can be too short to find significant TR changes.
Dr Fuster: I think these are very important questions. Of course, you have addressed one of the most important limitations of this retrospective study, because a retrospective study has probably two problems. One problem is the potential selection bias, because there is no randomisation, and the other problem is the lack of retrospective data. So effectively we have a lack of important data with respect to tricuspid valve annulus diameter and right ventricular function in our quantitative echocardiographic assessment. So this is an important limitation, of course. I think every cardiac surgeon knows that the annulus of the tricuspid valve is an important predictor of development of late functional TR and probably a liberal use of annuloplasty in lower grades of TR severity is advisable. But in our case we have these important limitations.
We frequently ask for all this information from our cardiologists, and our echocardiographers and, even today, it is difficult for us to access this information. In a retrospective way we have analysed the information of the echocardiographic reports, and most of the patients did not have dilated tricuspid valve annulus, with absence of suggestive signs of rheumatic involvement (leaflet fusion, thickening or stenosis), but this is the only data we have available.
In the second place, the selection bias is obviously present in several points, probably with respect to the aggressiveness of the rheumatic disease. Consequently group A with a lack of complete preservation, probably had more extensive scarring, fibrosis and calcification than group B. Anyway, we have addressed the problem of selection bias with a propensity score analysis. Both groups were comparable with respect to other clinical variables and the results are the ones we have presented. But this is logically another potential limitation.
Finally, you have mentioned the issue of regional contractility. In a future study we are trying to establish a comparison of both groups by means of studying the regional contractility, not only of the left ventricle but also of the right ventricle. There are experimental and clinical studies that have demonstrated that anterior chordal transection can impair not only leftventricular regional contractility, but also right ventricular contractility, especially at the level of the apical and septal segments of the right ventricle. And probably these changes can also predispose to the development of late functional TR in these cases. So I think it is a matter of a future study in our patients.
